Timothy Rolph - Jan 7, 2025 Form 4 Insider Report for Akero Therapeutics, Inc. (AKRO)

Role
Chief Scientific Officer
Signature
/s/ Jonathan Young, Attorney-in-Fact
Stock symbol
AKRO
Transactions as of
Jan 7, 2025
Transactions value $
$0
Form type
4
Date filed
1/10/2025, 07:38 PM
Previous filing
Dec 30, 2024
Next filing
Jan 29, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AKRO Common Stock Gift $0 -14K -7.6% $0.00 170K Jan 7, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of the Issuer's Common Stock that the reporting person donated as a gift to a donor advised fund.